A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer.
Lee, Alice W
A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer. [electronic resource] - International journal of cancer Dec 2016 - 2646-2654 p. digital
Publication Type: Journal Article; Meta-Analysis
1097-0215
10.1002/ijc.30274 doi
Age Factors
Aged
Aged, 80 and over
Alleles
Alternative Splicing
Case-Control Studies
Disease Susceptibility
Estrogen Replacement Therapy--adverse effects
Female
Gene-Environment Interaction
Genome-Wide Association Study
Genotype
Humans
Menopause
Middle Aged
Odds Ratio
Ovarian Neoplasms--diagnosis
Polymorphism, Single Nucleotide
Population Surveillance
Risk
Telomerase--genetics
A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer. [electronic resource] - International journal of cancer Dec 2016 - 2646-2654 p. digital
Publication Type: Journal Article; Meta-Analysis
1097-0215
10.1002/ijc.30274 doi
Age Factors
Aged
Aged, 80 and over
Alleles
Alternative Splicing
Case-Control Studies
Disease Susceptibility
Estrogen Replacement Therapy--adverse effects
Female
Gene-Environment Interaction
Genome-Wide Association Study
Genotype
Humans
Menopause
Middle Aged
Odds Ratio
Ovarian Neoplasms--diagnosis
Polymorphism, Single Nucleotide
Population Surveillance
Risk
Telomerase--genetics